Citation

Miodownik C, Lerner V. Clin. Neuropharmacol. 2000; 23(6): 335-337.

Copyright

(Copyright © 2000, Lippincott Williams and Wilkins)

DOI

10.1097/00002826-200011000-00007

PMID

11575868

Abstract

Risperidone has been primarily marketed for the treatment of schizophrenia. There are reports about its potential role for the treatment of affective illness. We report here another case of a patient with psychotic depression who was treated successfully with risperidone as monotherapy. This case report suggests that risperidone can be an efficient treatment mode for psychotic depression; however, it needs more data based on controlled study.

Language: en

Keywords

Adult; Antipsychotic Agents; Depressive Disorder; Female; Humans; Psychotic Disorders; Risperidone; Suicide, Attempted